Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Input: Consider Input: Paragraph: The lawsuit marks the first multi-plaintiff trial in the litigation over whether glyphosate, Roundup's active ingredient, is carcinogenic, and is the first trial outside of California. It is being held in St. Louis, where Monsanto was headquartered before Bayer bought the company in a $63 billion deal in 2018. Three consecutive juries found the company liable for causing cancer with damages of tens of millions of dollars awarded to each plaintiff. Bayer is appealing those verdicts. Court-appointed mediator Ken Feinberg has put the number of Roundup cancer claimants at more than 75,000 while Bayer said the claims it has been served with in court were below 50,000. Bayer's share price has tumbled since the first verdict in August 2018 but the stock rose 3% on Friday after Bloomberg reported a possible out-of-court settlement with some plaintiffs that could lead to a total payout of about $10 billion. While traders said the market likes the idea of Bayer settling the litigation, some cautioned that the prospect of a comprehensive deal remained uncertain. Analysts have estimated the size of any such settlement at $8-$12 billion. While most plaintiffs' lawyers have agreed to postpone trials pending negotiations, some have decided to pursue their clients' day in court. The case in Missouri's Circuit Court for the 22nd Judicial Circuit of the City of St. Louis is scheduled to last several weeks, with both sides presenting extensive scientific evidence through expert witnesses. Bayer denies all allegations that Roundup or glyphosate causes cancer, saying decades of independent studies have shown the world's most widely used weed killer to be safe for human use and noting that regulators around the world have approved the product. "At the end of the day, this trial should come down to the weight of the science, and we remain confident in the extensive scientific record and regulatory assessments that support the safety of our glyphosate-based herbicides and that they do not cause cancer," the company said in a statement. Several court cases have been postponed by both parties in the past to expedite settlement talks. By pursuing the St. Louis trail The Miller Firm LLC, a key player in the litigation, is seeking to increase pressure on Bayer. The case involves the claims of Bryce Batiste from Louisiana, Ann Meeks from Florida, Glen Ashelman from Pennsylvania and Christopher Wade, a St. Louis resident. All four have been diagnosed with non-Hodgkin's lymphoma, a blood cell cancer that plaintiffs in the litigation allege is caused by Roundup. Some legal experts said Bayer could benefit from a home advantage in the St. Louis trial, where Monsanto has century-old roots. But juries in the city are also known to dole out massive damages awards against large corporations. Claim: Bayer faces fourth U.S. Roundup cancer trial in Monsanto's hometown.

Output: Bayer AG is set to face a fourth U.S. jury trial over allegations that its Roundup weed killer causes cancer, with four cancer patients in the hometown of its agricultural subsidiary Monsanto scheduled to begin making their case on Friday.

Input: Consider Input: Paragraph: "One theme Sen. Bernie Sanders has repeatedly touched on during his run for the Democratic nomination for president has been the high cost of prescription drugs. His comment during the Feb. 11 Democratic debate at the University of Wisconsin-Milwaukee was typical as he rattled off a list of problems with the U.S. health care system: ""In America, we pay, by far, the highest prices in the world for prescription drugs."" We asked the Sanders campaign for the source of his claim. We didn't get a response. So we searched on our own. One organization that tracks such things is the International Federation of Health Plans, based in London. Their latest price report, from 2013, lists eight common drugs. Compared with England, the Netherlands, Spain, Switzerland and Canada, U.S. prices were far higher, sometimes dramatically so. Consider Nexium, the medicine widely used to treat acid reflux. A prescription that would cost $60 or less in other countries costs, on average, $215 in the United States. And that's just the average. Prices vary widely in this country: In 5 percent of the cases, the cost was $395. ""What Bernie says is true. There's nowhere that pays the same price as America,"" said Tom Sackville, the federation's CEO. In addition, ""there is this huge variation in price across America. Anything above the average is quite unjustified. When you get up to the 95th percentile, you're talking grand robbery."" The findings were similar in an April 2013 study published in the journal Health Affairs, which looked at the prices of brand name drugs in the United States, United Kingdom, Switzerland, Germany, France, Canada and Australia. In each of the three years studied -- 2005, 2007 and 2010 -- U.S. prices were consistently higher. The one exception: Switzerland. In addition, researchers found that, between 2005 and 2010, ""the gap between the United States and other countries seemed to widen."" And it wasn't just new drugs being embraced first in the United States that was driving up costs. They concluded that ""prices for older products rose faster in the United States than in other countries."" But Joel Farley of the University of North Carolina at Chapel Hill's Eshelman School of Pharmacy cautioned that the rule doesn't always apply to generic drugs. A 2008 comparison of 19 generic drugs found that some U.S. prices were lower than Canadian prices. ""In some cases it has to do with availability,"" he said. In other cases, a country may set the drug price low and in that fixed-price market ""there's no incentive to go lower."" The Wall Street Journal published an analysis in December that concluded 98 percent of 40 top branded drugs were more expensive in the United States than in England. In Norway, 93 percent of the 40 top branded drugs cost lessthan in the United States. And in Ontario, a comparison of 30 drugs showed that U.S. prices were also higher for 93 percent of the products. Why are the brand name prices so much lower in other countries, and why is there so much variation in the United States? Big customers can negotiate big discounts. So the countries with socialized medicine have a lot of leverage at the negotiating table, the experts told us. In the United States, hospitals, wholesalers and insurance companies all do their own negotiations. The Veterans Administration can -- and does -- negotiate dramatically lower prices. Under Medicaid, the drug companies are required to provide their medicines at a price that's as low as it is for any of their regular customers. But Medicare has been prohibited by law from negotiating lower prices since 2006, and that's a huge chunk of the U.S. health care industry. (When Barack Obama was first running for president, he promised to repeal that Bush-era restriction, but then backed off in an attempt to get passage of the Affordable Care Act.) The pharmaceutical industry says it needs the extra income to pay for research to keep new, desperately needed drugs coming. But with everyone getting a bargain, Americans are financing that research for the rest of the world, experts told us. Yet there's another way to look at the issue, said Amitava Dasgupta, a clinical toxicologist at the University of Texas Health Science Center at Houston. The tablet that costs a dollar in the United States may only cost 20 cents in India, but that drug is far more expensive to the average person in India because their income is so much lower. ""The U.S. subsidizes research for the world,"" he said. ""But I would look at that as philanthropy."" Our ruling Sanders said, ""In America, we pay, by far, the highest prices in the world for prescription drugs."" When it comes to brand-name drugs, which yield the highest profit for the pharmaceutical industry, studies support Sanders' claim -- although not always on a drug-by-drug basis. In addition, the differences in price can be dramatic because the U.S. health care system is so splintered, and Medicare is prohibited by law from using its market share to bargain for lower prices. We found one study comparing the United States and Canada that found exceptions for generic drugs, where the profit margin is much lower and which make up a much smaller share of prescription drug spending. But on balance," Claim: In America, we pay, by far, the highest prices in the world for prescription drugs.

Output: "Sanders said, ""In America, we pay, by far, the highest prices in the world for prescription drugs."" When it comes to brand-name drugs, which yield the highest profit for the pharmaceutical industry, studies support Sanders' claim -- although not always on a drug-by-drug basis. In addition, the differences in price can be dramatic because the U.S. health care system is so splintered, and Medicare is prohibited by law from using its market share to bargain for lower prices. We found one study comparing the United States and Canada that found exceptions for generic drugs, where the profit margin is much lower and which make up a much smaller share of prescription drug spending."

Input: Consider Input: Paragraph: You need the right mix of factors to create ground-level ozone: sunlight, snow cover, little to no wind and, of course, emissions from the oil and gas industry which arrived in force more than a decade ago in the Jonah and Pinedale gas field. And this year the factors have been right more often than usual. Friday was the 12th ozone action day of the season a warning system from the Wyoming Department of Environmental Quality that forces industry to pull back when conditions for ozone are expected. It's a record number for recent years, and action days were issued for Saturday and Sunday as well. But there's something more troubling in the case of the Boulder area: ground-level ozone is regularly forming despite precautions. Breathing it in can cause a variety of health problems, from chest pain to reduced lung function. For reasons still unclear to state regulators, in one corner of the Upper Green, the rules and regulations that reversed an air quality crisis more than a decade ago haven't been enough, the Casper Star-Tribune reported . "We don't have all the answers, yet," Keith Guille, spokesman for the state Department of Environmental Quality, said. "It's definitely not being ignored. We understand that the public is concerned, as we are." ___ The Upper Green River Basin is a bowl-shaped area wedged between the Wind River and Wyoming ranges. That landscape holds bad air in place when there is no wind. Snowy and sunny years are worse for ozone action days, as was the case in 2017, the last year that ozone action days were a regular occurrence. There was nearly three times the amount of precipitation during the 2017 winter ozone season compared to historical averages, according to a fact sheet from the Wyoming Department of Environmental Quality. But the controllable factor, and the one that once precipitated the great ground level ozone crisis in the basin, is oil and gas. More than a decade ago, oil and gas activity degraded air quality to the point it was comparable to Los Angeles, and it changed the way Wyoming regulated industry in the basin, its pipes and compressor stations, trucks and holding tanks. Those regulations have been effective in driving down emissions. The rules are some of the strongest in the country and have inspired attempts by the Environmental Protection Agency and the Bureau of Land Management to institute similar rules across federal and Native American land though in both cases the Trump administration has recently pulled back on some of those standards. In addition to the ozone action days, Upper Green rules cover the use of equipment to track leaks and regular checks of infrastructure for damage. And during ozone season, in late winter and early spring, action days are an important part of how the Upper Green manages emissions. In the mix of ozone contributing factors, oil and gas emissions are the one thing regulators can pull back to try and keep ozone at bay. Action days are declared by the Wyoming Department of Environmental Quality as having the potential to create ground-level ozone. Operators in the Upper Green respond by following contingency plans to reduce emissions, such as reducing refueling and cutting truck idling. This year industry has had to scale back over and over. ___ Jonah Energy, which operates in a different area of the basin from where the Boulder exceedances have been happening, has scaled back its operations considerably due to action days this year, said Paul Ulrich, spokesman for the oil and gas firm. "Small stuff. We're turning off air heaters on pads during the day. Big stuff, shutting down workover rigs," Ulrich said. "Those have immediate production, operational and financial impacts that we are bearing." Jonah has demobilized its completion crew holding off on finishing wells and bringing them online until mid-April and it is delaying blowing down wells, he said. "I will tell you though, we plan for it. We train for it and we understand that we have an obligation to do everything we possibly can," Ulrich added. The outcome of those actions is evidenced in the lack of ozone exceedances, over an eight-hour period, this year near Jonah's operations, he said. But the rules and practices of today may not be enough, if ozone is still forming in the Upper Green, according to the DEQ. "In 2019, we feel whether or not you have a snow pack or not, we don't want to see those levels above the standard," said Guille, of the Department of Environmental Quality. Nancy Vehr, administrator of the Air Quality Division of the Wyoming Department of Environmental Quality, said she began reaching out to operators in the Boulder area, where more than 30 companies mostly oil and gas firms work, when the ozone spike began about two weeks ago. She asked them to find more ways to voluntarily cut emissions. And they did. But what's been unique about the Boulder problem this year is that the elevated ozone levels have been persistent, Vehr noted. "We've never had an eight-day stretch in one location," she said. But that area has been a problem in the past. Whether it's temperature or other factors, the Boulder monitor often picks up more air quality concerns than others across the basin, she said. Ulrich of Jonah said the ozone spikes of this year are a mystery, but it does appear to be isolated and not reflected across the basin, he explained. "The challenge for this particular season is it's been one monitoring station," he said. "From a scientific standpoint, that's a very new challenge for us all, to fully understand between operators and DEQ and others what's going on at that station." Everyone is going to have to come back to the table, Ulrich said. "We know we need to take a hard look at it after this year," he said. Vehr echoed that confidence in current rules, noting that it would be easier to look back over the data in retrospect and analyze patterns. When air quality was at its worst in the Upper Green, you could see it like an orange haze, said Bousman of Boulder. Despite the exceedances this year, the rancher said he hadn't noticed the air quality being any different. Like everyone else, he wondered what was going on at the Boulder monitor, whether it was working properly and how much of the ozone problem was natural. There is deeper snow up that way, he said. Still, the spikes in safe levels had caught everyone's attention in the Upper Green, even though they've been addressing ozone since 2005 or 2006. "I think, collectively, we thought we were on top of it, so to speak," Bousman said. "Now, I'm not so sure." ___ Information from: Casper (Wyo.) Star-Tribune, http://www.trib.com Claim: Wyoming ozone levels puzzle officials.
Output: Joel Bousman wasn't sure if ozone would be a problem Friday, despite a warning from the state. The snow covered the sage brush and the wind was less than 10 miles per hour both bad signs. On the other hand, it had been overcast most of the day at the Sublette County commissioner's ranch near Boulder a small community about 12 miles southeast of Pinedale, within view of the Wind River Mountains.